Skip to main content
Caplight Logo









SCOHIA PHARMA, Inc.

SCOHIA PHARMA, Inc.

Private
FujisawaHealthcare & Life Scienceshttps://www.scohia.com/

Last Round

VC Round

May 28, 2026

Total Funding Raised

$3.98M

Company Overview

SCOHIA PHARMA, Inc. is a drug discovery bioventure that develops specialty biopharmaceuticals for the treatment of lifestyle-related diseases, including cardiovascular, metabolic, and renal conditions.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

drug discoverybiopharmaceuticalsmall-molecule therapeuticsbiotechdrug licensingmetabolic diseasescardiovascular researchrenal conditionsrare endocrine disordersmedicinal chemistryclinical developmentR&D pipelinepharma pipelineout-licensingbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SCOHIA PHARMA, Inc. Comparables

Compare SCOHIA PHARMA, Inc. with similar companies based on industry and business-model similarity.

SCOHIA PHARMA, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
OrsoBio
76%
Viking Therapeutics, Inc.
72%
Cardurion Pharmaceuticals
65%

SCOHIA PHARMA, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMay 28, 2026
SeedSep 27, 2024
Joint VentureMar 13, 2017

SCOHIA PHARMA, Inc. Investors

Notable investors and investment history

SCOHIA PHARMA, Inc. investors
InvestorRounds
Tohoku University Venture PartnersVC Round
DCI PartnersVC Round
Bio-Sight CapitalVC Round
Beyond Next VenturesVC Round
Innovation Network Corporation of JapanJoint Venture
DBJ CapitalSeed, VC Round
Gemseki Investment Inc.Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 19, 2026

    Monthly visitors grew 81% MoM, from 1.9K to 3.4K.

  • Sep 27, 2024

    $4M raised from DBJ Capital and Gemseki Investment Inc.

SCOHIA PHARMA, Inc. Filings

Explore SEC and related filing metadata, where available.

SCOHIA PHARMA, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about SCOHIA PHARMA, Inc.'s valuation, stock price, and market status.

Is SCOHIA PHARMA, Inc. a public or private company?

SCOHIA PHARMA, Inc. is a private company.

What is the current stock price of SCOHIA PHARMA, Inc.?

SCOHIA PHARMA, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is SCOHIA PHARMA, Inc. worth (valuation)?

Valuation information for SCOHIA PHARMA, Inc. is not publicly available.

Can I buy SCOHIA PHARMA, Inc. stock?

SCOHIA PHARMA, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was SCOHIA PHARMA, Inc.'s last funding round?

SCOHIA PHARMA, Inc.'s most recent funding round was VC Round on May 28, 2026.

Who are the main investors in SCOHIA PHARMA, Inc.?

Key investors in SCOHIA PHARMA, Inc. include Beyond Next Ventures, Innovation Network Corporation of Japan.

Will SCOHIA PHARMA, Inc. IPO soon?

No public IPO plans have been announced for SCOHIA PHARMA, Inc..

How can I track SCOHIA PHARMA, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SCOHIA PHARMA, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersFujisawa
Employee Range1
Year Founded2017
Last FundingMay 28, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?